4th Quarter - Report

HEALTHFUTURES, LLC for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institute of Standards & Technology (NIST); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5116 (111th), H.R. 5440 (111th)

Health Issues HCR

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues P.L. 111-148/P.L. 111-152, Affordable Care Act, health care reform in general

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Institute of Standards & Technology (NIST); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.